©The Author(s) 2019.
World J Hepatol. Aug 27, 2019; 11(8): 638-645
Published online Aug 27, 2019. doi: 10.4254/wjh.v11.i8.638
Published online Aug 27, 2019. doi: 10.4254/wjh.v11.i8.638
Table 1 Demographic data
| Value | % | |
| Median age | 59.30 | 12.44 |
| Sex: Male (%): Female (%) | 243 (62.15) | 148 (37.85) |
| Etiology of liver disease | ||
| Alcohol | 45 | 11.54 |
| Nonalcoholic steatohepatitis | 47 | 12.05 |
| Hepatitis C | 48 | 12.31 |
| Hepatitis B | 1 | 0.26 |
| Hepatocellular carcinoma | 1 | 0.26 |
| Autoimmune hepatitis | 20 | 5.13 |
| Cryptogenic | 1 | 0.26 |
| Multi-visceral | 14 | 3.59 |
| Primary sclerosing cholangitis | 25 | 6.41 |
| Primary biliary cholangitis | 12 | 3.08 |
| Alpha-1-antitrypsin-Deficiency | 5 | 1.28 |
| Hepatic vein thrombosis | 2 | 0.51 |
| Hemochromatosis | 1 | 0.26 |
| Total parental nutrition related | 1 | 0.26 |
| Polycystic liver disease | 1 | 0.26 |
| Familial intrahepatic cholestasis | 1 | 0.26 |
| Cholangiocarcinoma | 2 | 0.51 |
| Primary oxaluria | 3 | 0.77 |
| Multiple | 161 | 41.0 |
- Citation: Bhogal N, Dhaliwal A, Lyden E, Rochling F, Olivera-Martinez M. Impact of psychosocial comorbidities on clinical outcomes after liver transplantation: Stratification of a high-risk population. World J Hepatol 2019; 11(8): 638-645
- URL: https://www.wjgnet.com/1948-5182/full/v11/i8/638.htm
- DOI: https://dx.doi.org/10.4254/wjh.v11.i8.638